insights_auto
Hvorfor er 2269 faldet med 2,95%?
Dyk dybere nedchevron_right
2269:HKG
WuXi Biologics (Cayman) Inc
49,74Â HK$
arrow_downward
-2,95%(-1,51) 1D
14. okt., 16.08.24 GMT+8 · HKD
search
Alle symboler
| Symbol | Pris | Ændring | Ændring i % |
|---|
insights_autoGenererer vigtig indsigt for 2269...
Ã…bn
50,60Â HK$
Høj
51,35Â HK$
Lav
49,40Â HK$
Markedsværdi
204,77Â mia.
Gns. vol.
30,95Â mio.
Volumen
25,22Â mio.
P/E-forhold
35,58
Højeste i 52 uger
58,00Â HK$
Laveste i 52 uger
28,48Â HK$
Indtægt pr. aktie
1,40Â HK$
Aktier i omløb
1,23Â mia.
Antal ansatte
15Â t
Ã…bn
50,60Â HK$
Høj
51,35Â HK$
Lav
49,40Â HK$
Markedsværdi
204,77Â mia.
Gns. vol.
30,95Â mio.
Volumen
25,22Â mio.
P/E-forhold
35,58
Højeste i 52 uger
58,00Â HK$
Laveste i 52 uger
28,48Â HK$
Indtægt pr. aktie
1,40Â HK$
Aktier i omløb
1,23Â mia.
Antal ansatte
15Â t
Nyhedshistorier
Fra webkilder og nyhedspartnere
Invezz
·
for 2 dage siden
Dow Jones åbner 190 point højere, investorer ser mod bankindtjening og inflation
Traders Union
·
for 7 timer siden
Mike McGlone: Kobberfutures og S&P 500 når rekordhøj korrelation
Invezz
·
for 1 dag siden
Dow lukker 198 point højere, mens amerikanske aktier ender blandet før regnskaber
Invezz
·
for 2 dage siden
Top 3 katalysatorer for S&P 500-indexet denne uge: obligationer, indtjeningssæson, CPI
Profil
WuXi Biologics is a global Contract Research Development and Manufacturing Organization that provides open-access, integrated technology platforms for biologics drug development.
WuXi Biologics' roots date back to 2010, when it was founded as a division of WuXi AppTec and began building out capabilities and facilities required for biologics discovery, development and good manufacturing practices. After being spun off from its parent, WuXi Biologics went public on the Hong Kong Stock Exchange in June 2017.
As of 2021, WuXi Biologics has 18 manufacturing sites including ten in China, three in the United States, two in Ireland, two in Germany, and one in Singapore.
In August 2020, WuXi Biologics was selected to become a component of the Hang Seng Index in Hong Kong.
In January 2024, WuXi Biologics' share price fell on news that the United States Congress had introduced legislation to block any federal government contracts with the company due to national security concerns. The concerns stem from allegations, denied by the company, that it has worked closely with the People's Liberation Army as a part of the Chinese Communist Party's military-civil fusion strategy. Wikipedia
Om WuXi Biologics (Cayman) Inc
Administrerende direktørZhisheng Chen
Ansatte14,7Â t
Grundlagt2010
Hovedsæde-
Sektor-
Websitewuxibiologics.com